高级检索
    李安娜. MET抑制剂耐药新突变位点Y1248H和D1246N再现[J]. 循证医学, 2017, 17(3): 130-131. DOI: 10.12019/j.issn.1671-5144.2017.03.002
    引用本文: 李安娜. MET抑制剂耐药新突变位点Y1248H和D1246N再现[J]. 循证医学, 2017, 17(3): 130-131. DOI: 10.12019/j.issn.1671-5144.2017.03.002
    shu
    LI An-na. The Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors Cancer Appear Again[J]. Journal of Evidence-Based Medicine, 2017, 17(3): 130-131. DOI: 10.12019/j.issn.1671-5144.2017.03.002
    Citation: LI An-na. The Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors Cancer Appear Again[J]. Journal of Evidence-Based Medicine, 2017, 17(3): 130-131. DOI: 10.12019/j.issn.1671-5144.2017.03.002
    shu

    MET抑制剂耐药新突变位点Y1248H和D1246N再现

    The Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors Cancer Appear Again

      摘要
      • HTML全文
      • 参考文献(4)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回